Business

Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (FULC) on Behalf of Shareholders for Possible Securities Law Violations

New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox Kilsheimer LLP is investigating...